The Iowa City VA Health Care System has a requirement for Radio Pharmaceuticals Axumin not to exceed 22 doses. Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment. Email responses or questions to the contracting specialist david.malm@va.gov no later than the closing date displayed on the attached solicitation.
David Malm
701-239-3700 ext 9-4596
david.malm@va.gov
david.malm@va.gov